José María Abad-Díez
Biographic Data
| ID | 7891400 |
|---|---|
| NAME | José María Abad-Díez |
| GIVEN NAMES | José María |
| FAMILY NAME | Abad-Díez |
| SIGNATURE | ABAD-DÍEZ J M |
| AFFILIATIONS | Servicio Aragonés de Salud |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease
The objective of this study was to analyse persistence to lipid-lowering drug use for primary prevention of cardiovascular disease (CVD) in a new users cohort, to explore all-cause and cardiovascular related morbidity, comorbidity and mortality in this group and, finally, to study the relationship between persistence and morbimortality. We selected subjects who started lipid-lowering treatment for primary prevention of CVD between 1 January 2010 …
Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure
With appropriate validation, the methodologies of the present study could be incorporated in the routine monitoring of the prescribing profile of general practitioners. This could not only enable evaluation of their performance, but also target groups of outlier patients and foster analyses of the causes of unusually high pharmacy expenditures among them. This interpretation of pharmacy expenditure gives new clues for the efficiency in utilisatio…
No prominent works on this page.
Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure
With appropriate validation, the methodologies of the present study could be incorporated in the routine monitoring of the prescribing profile of general practitioners. This could not only enable evaluation of their performance, but also target groups of outlier patients and foster analyses of the causes of unusually high pharmacy expenditures among them. This interpretation of pharmacy expenditure gives new clues for the efficiency in utilisatio…
New Male Users of Lipid-Lowering Drugs for Primary Prevention of Cardiovascular Disease
The objective of this study was to analyse persistence to lipid-lowering drug use for primary prevention of cardiovascular disease (CVD) in a new users cohort, to explore all-cause and cardiovascular related morbidity, comorbidity and mortality in this group and, finally, to study the relationship between persistence and morbimortality. We selected subjects who started lipid-lowering treatment for primary prevention of CVD between 1 January 2010 …
Internal Medicine (2 works) · Medicine (2 works) · Observational study (2 works) · Biostatistics (1 work) · Chronic Disease Management Strategies (1 work) · Comorbidity (1 work) · Confounding (1 work) · Diabetes, Cardiovascular Risks, and Lipoproteins (1 work) · Disease (1 work) · Environmental health (1 work)